Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.ady4492
Affiliations:
6
Authors:
12
Go to article
Institutions Authors Share
University of Vermont (UVM), United States of America (USA)
6.000000
 0.50
Wake Forest University (WFU), United States of America (USA)
4.833333
 0.40
Atrium Health Wake Forest Baptist Medical Center, United States of America (USA)
1.166667
 0.10
Interested in Medicinal and Biomolecular Chemistry?